Phillip Decker focuses his practice on technology transactions and patent and intellectual property litigation in the life sciences and technology industries.
Phil has represented clients across a variety of life sciences technologies, including immunoassay, protein expression/modulation, antibody, and small molecule therapeutics. His representative transactions include development and collaboration agreements, intellectual property licenses and material transfer agreements.
In addition to his transactional work, Phil’s experience includes Hatch-Waxman litigation, contract dispute arbitration, unfair imports litigation at the United States International Trade Commission, and inter partes review (IPR) proceedings before the United States Patent and Trademark Office.
Prior to joining Fenwick & West, Phil was an associate at a nationally recognized intellectual property boutique in Washington, D.C. He also served as Law Clerk to the Honorable Pauline Newman of the United States Court of Appeals for the Federal Circuit.
Phil received his J.D. from George Mason University School of Law in 2010. While attending law school, he served as a Legal Extern in the Judicial Committee of the United States House of Representatives during debates over the America Invents Act, and as an in-house summer associate in the patent department of a major pharmaceutical company. In 2005, Phil earned a double degree in Microbiology and International Studies from the University of Washington, with research focus on biofilm formation by the nosocomial pathogen Pseudomonas aeruginosa. Following graduation, Phil earned a research training award from the National Institutes of Health and conducted two years of post-baccalaureate research on the topic of bacterial gene regulation and completed graduate-level coursework in molecular immunology.
Phil is admitted to practice in Washington, Massachusetts and Washington D.C. He is also registered to practice before the United States Patent and Trademark Office.
Publications and Speaking Engagements:
- Co-author. “The Bacteriophage T4 activator MotA and the beta-flap tip of RNA polymerase target the same set of sigma-70 C-terminal residues.” J. Biological Chemistry (2011).
- Co-author, "The Common-Interest Privilege May Prevent Waiver of Attorney-Client Privilege in Documents Shared Between Litigants and IP-Licensing Consultants,” LES Insights (2011).
- Speaker, “Intellectual Property Rights and Economic Development,” U.S.P.T.O. Global Intellectual Property Academy, Alexandria, VA (November 2005, April 2006 and January 2007).